EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Effects of semaglutide, a GLP-1 receptor agonist, on food preferences in Japanese subjects with type 2 diabetes and visceral fat accumulation

Tomoyuki Hara, Yuya Fujishima, Yu Kimura, Kohei Fujii, Yusuke Kawachi, Hirofumi Nagao, Yoshinari Obata, Shiro Fukuda, Naoko Nagai, Hitoshi Nishizawa, Iichiro Shimomura

Endocrine Journal · 2026 · 73 (5) · 607-619

DOI: 10.1507/endocrj.ej25-0402 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Endocrine Journal, 2026. Verfasst von Tomoyuki Hara und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka, Osaka 565-0871, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Food Preferences, Glucagon-Like Peptide-1 Receptor Agonists, Hypoglycemic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Lotte Foundation, Japan Society for the Promotion of Science, Japan Association for Diabetes Education and Care.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity and type 2 diabetes mellitus (T2DM) are growing global health burdens, with dietary patterns, particularly high intake of carbohydrate- and fat-rich foods, contributing to disease progression. Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA), is effective for both lowering blood glucose and reducing weight; however, its effects on food preferences for specific macronutrients remain unclear. In this retrospective observational study, we enrolled 32 obese subjects with T2DM who were hospitalized for glycemic control, including 20 who started semaglutide treatment (the Sema group) and 12 who did not receive GLP-1RA therapy. Eating behaviors were assessed using the Dietary Behavior Questionnaire from the Japan Society for the Study of Obesity (JASSO-DBQ), and food preferences for carbohydrates, fat, protein, and dietary fiber were quantitatively evaluated using the Japan Food Preference Questionnaire (JFPQ). Thirteen subjects in the Sema group and eight in the Non-GLP-1 group completed 6-months of follow-up. The Sema group showed significant decreases in HbA1c levels (-1.1%) and body weight (-5.7 kg), with fat loss exceeding skeletal muscle loss. Significant decreases were observed in eating behavior scores for "Eating Motives," "Way of Eating," and "Dietary Content." Notably, semaglutide significantly reduced preferences for sweet and non-sweet carbohydrates and non-sweet fats, without changing protein or dietary fiber preferences. In particular, significant reductions were observed in preferences for Japanese staple foods (e.g., white rice and udon/soba) and high-fat snacks. The Non-GLP-1 group showed no significant changes in food preferences for any of the nutrient categories. In summary, semaglutide treatment in obese subjects with T2DM facilitated weight loss, in part by altering food preferences, which potentially contributed to its metabolic benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Food PreferencesGlucagon-Like Peptide-1 Receptor AgonistsHypoglycemic AgentsObesitySemaglutideAgedFemaleHumansMaleMiddle AgedBlood GlucoseFeeding BehaviorGlycated HemoglobinJapanRetrospective StudiesWeight LossEast Asian People

Stichwörter der Autor:innen

Eating behaviorFood preferenceGLP-1 receptor agonistObesityType 2 diabetes mellitus

Substanzen

Blood GlucoseGlucagon-Like Peptide-1 Receptor AgonistsGlycated HemoglobinHypoglycemic AgentsSemaglutide

Autor:innen und Institutionen

  • Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka, Osaka 565-0871, Japan.
  • Department of Diabetes Endocrinology, Rinku General Medical Center, Osaka 598-0048, Japan.
  • Department of Metabolism and Atherosclerosis, Graduate School of Medicine, The University of Osaka, Osaka 565-0871, Japan.
  • Division of Nutrition Management, The University of Osaka Hospital, Osaka 565-0871, Japan.

Förderung

  • Lotte Foundation
  • Japan Society for the Promotion of Science
  • Japan Association for Diabetes Education and Care
  • Manpei Suzuki Diabetes Foundation

Zitieren

APA

Hara, T., Fujishima, Y., Kimura, Y., Fujii, K., Kawachi, Y., Nagao, H., Obata, Y., Fukuda, S., Nagai, N., Nishizawa, H., & Shimomura, I. (2026). Effects of semaglutide, a GLP-1 receptor agonist, on food preferences in Japanese subjects with type 2 diabetes and visceral fat accumulation. Endocrine Journal, 73(5), 607-619. https://doi.org/10.1507/endocrj.ej25-0402

Vancouver

Hara T, Fujishima Y, Kimura Y, Fujii K, Kawachi Y, Nagao H, et al. Effects of semaglutide, a GLP-1 receptor agonist, on food preferences in Japanese subjects with type 2 diabetes and visceral fat accumulation. Endocrine Journal. 2026;73(5):607-619. doi:10.1507/endocrj.ej25-0402

BibTeX
@article{Hara2026,
  author = {Hara, Tomoyuki and Fujishima, Yuya and Kimura, Yu and Fujii, Kohei and Kawachi, Yusuke and Nagao, Hirofumi and Obata, Yoshinari and Fukuda, Shiro and Nagai, Naoko and Nishizawa, Hitoshi and Shimomura, Iichiro},
  title = {Effects of semaglutide, a GLP-1 receptor agonist, on food preferences in Japanese subjects with type 2 diabetes and visceral fat accumulation},
  journal = {Endocrine Journal},
  year = {2026},
  volume = {73},
  number = {5},
  pages = {607--619},
  doi = {10.1507/endocrj.ej25-0402}
}
Kostenlos starten →